|
Welcome
Life sciences is an industry where risk management and issues management are day-to-day considerations - how to progress cash hungry projects to the next "value inflection" point and extract value through partnering, sales or equity transactions; and how to cope when "biology" shows you (again) how smart it is and how hard anticipating in vivo reactions can be. So add to that the general turmoil in the financial markets and a pharma industry looking for "models for change" and most of us find ourselves in pretty turbulent waters.
Risk sharing at all levels is thus the topic of the day - finding ways to work with all players (and payers!) in the value chain to ensure that good science makes good business sense.
At College Hill we aim to work closely with our clients to understand critical audiences, tailor messages to them and ensure that communications programmes deliver these messages at maximum impact. We believe our many years experience in the life science industry, working with many types of clients and business models, coupled with our understanding of how the future is changing, means that we are well placed to provide strategic communications counsel as well as practical support to ensure that communications programmes truly add value.
Our newsletter gives you a snap-shot of our activities and capabilities - we would be happy to discuss with you any ways in which you feel we can support your business in the months ahead. Do get in touch.
Sue Charles
Managing Partner, Life Sciences
|
|
Nature Paper
In March, Nature published a study by Santaris Pharma that demonstrated the first microRNA silencing in non-human primates. Using this news, College Hill was able to further increase media awareness of Santaris and its LNA-based therapeutics, securing both national and international coverage.
View Case Study |
|
Capital Markets
College Hill today is a multi-specialist communications business, aiming to meet the varied needs of our clients, from corporate communication and design through to internal engagement and crisis management. At the core of College Hill's offer is capital markets communications - at that point where the value of our clients' business is realised for its shareholders.
View News Item |
A Transformational Year
Having designed, copyedited and printed the previous five years' Annual Reports, College Hill 's life sciences team was again commissioned to create Oxford BioMedica's Annual Report for 2007. It was a significant year for the Company with the two key objectives achieved including partnering the lead product TroVax with sanofi aventis and starting clinical trials with ProSavin in Parkinson's disease patients.
View Case Study
|
|
| News |
 |
In June, with large amounts of new data expected on the K-Ras gene and companion diagnostics at ASCO 2008, College Hill was brought on board to maximise this opportunity and to raise the profile of DxS around the event, ensuring the Company received a share of voice. More... |
 |
College Hill's Life Sciences team has been appointed by ValiRx (AIM: VAL), London, UK, to develop and implement an integrated financial and corporate communications programme to raise its profile as a leader in the field of cancer therapeutics and diagnostics. More... |
 |
In June, College Hill was charged with organising key media interviews for Ranbaxy's CEO and Managing Director, Malvinder Singh following the announcement of the sale of his family's stake in Ranbaxy to Japanese pharma giant Daiichi Sankyo for $4.6 billion in cash. More... |
 |
BioInvent International, a Swedish company developing antibody therapeutics, secured a deal in June 2008 with Roche for the development and commercialisation of TB-403, which it had been developing in collaboration with ThromboGenics. College Hill has been working with BioInvent for three years and implemented international media relations around this deal, which coincided with a key industry conference in the US, in order to maximise coverage. More... |
 |
In July, entering a new stage in the Company's growth, College Hill was brought in to help reposition the Company and create a new visual identity, corporate image and materials, positioning Sloning as a state-of-the-art producer of SlonoMax™ libraries and their SlonoGene™ synthesis service. More... |
|
 |
May saw the launch of the inaugural College Hill Life Sciences Quiz Party. Fifteen teams battled it out in a competition of ten life science themed rounds set by guest Quiz Masters Mike Ward, Senior Editor of BioCentury and John Hodgson, Director of Critical I. For pictures and info from the night and to sign up for next year's event, please click here. |
 |
College Hill has recently been ranked 9th in PR Week's analysis of the top 25 UK Healthcare agencies. The ranking is based on gross revenues from its healthcare PR work by its life sciences sector team. More... |
 |
Congratulations to two of our clients for winning top honours at the prestigious London Stock Exchange Mediscience dinner awards in June. Corin won two awards on the night taking home the Best Performing techMARK Mediscience Share award, and the award for Chief Executive of the Year recognising former CEO Ian Paling's outstanding contributions. Acambis won the Breakthrough of the Year award for its West Nile vaccine partnership deal with Sanofi Pasteur, giving it increased access to the US market. More... |
 |
Having been initially appointed by Cryo-Save in April 2007 to work alongside its adviser Kaupthing Singer and Friedlander Capital Markets to advise on a placing and admission to AIM, College Hill continues to provide an on-going strategic communications counsel post IPO. More... |
 |
College Hill is pleased to be supporting Jeans for Genes Day in the UK on October 3rd. Every half an hour a baby is born in the UK with a genetic birth defect or genetic disorder which could seriously affect their lives. Jeans for Genes helps to provide much needed help, support and information for children and their families. More... |
|
New Biz: In recent months, College Hill's Life Sciences team has started working with a number of new clients including: Astex Therapeutics, Cell Medica, Ceram, DxS, GE Healthcare Wave Biotech, Genomic Vision, Improvision, Nabriva Therapeutics, NextGen Sciences, Polyphor, Syntropharma and ValiRx.
Conference Roundup: Analytica, European BioProcess International, ERBI's 10th Annual Biopartnering Exchange, BioVaria 2008, Bio€quity Europe 2008, BioFinance & BioInnovate 2008, BIO 2008 International Convention, MICROSCIENCE 2008. More...
|
|
|
Meet Us At
|
| Date |
Event |
Location |
Attending |
| 23 - 24 Sep 2008 |
Biotech in Europe Investor Forum |
Zurich, Switzerland |
Dr Douglas Pretsell, Justine Lamond |
| 25 Sep 2008 |
BIA Autumn Reception 2008 |
London, UK |
Sue Charles, Tony Stephenson |
| 7 - 9 Oct 2008 |
BIOTECHNICA |
Hannover, Germany |
Dr Robert Mayer |
| 12 - 14 Oct 2008 |
16th Annual BioPartnering Europe |
London, UK |
Sue Charles |
| 15 Oct 2008 |
Bench2Boardroom 2008 |
Cambridge, UK |
Lorna Cuddon |
| 20 Oct 2008 |
Nordic Venture Forum |
Copenhagen, Denmark |
Katja Stout |
| 17 - 19 Nov 2008 |
BIO-Europe 2008 |
Mannheim/Heidelberg, Germany |
Dr Douglas Pretsell |
| 18 Nov 2008 |
MEDICA 2008 |
Dusseldorf, Germany |
Jayne Lewis |
| 1 - 2 Dec 2008 |
European Venture Summit |
Dusseldorf, Germany |
Dr Douglas Pretsell |
| 9 - 10 Dec 2008 |
Genesis |
London, UK |
Sue Charles |
| 10 December 2008 |
SCRIP Awards |
London, UK |
Sue Charles, Katja Stout |
|
| People |
| Here are some team additions and promotions: |
|
|
 College Hill recently acquired Razor - a corporate communications consultancy. Founded in 1999, Razor built a leading reputation in international risk management and business continuity communications, particularly in the food and drinks industry. Its existing clients include a wide range of FMCG food brands and food ingredient manufacturers across Europe, as well as clients in other sectors, including property and chemicals. More...
|
| College Hill group - News |
College Hill Extends Public Affairs Team
College Hill recently announced that it had invested in Communiqué, the UK public affairs consultancy that is recognised for its longstanding high quality reputation in local community and stakeholder consultation and local authority relations. Communiqué, established for over 20 years and based in Westminster, will work alongside College Hill's existing public affairs group College Public Policy, which is led by Warwick Smith. 'Communiqué has a particular strength in local politics and engagement that will complement the needs of both our national and international clients,' says Warwick. 'It has built a strong team and excellent client relationships.'
Read this press release...
|
College Hill Builds German Presence
In May, College Hill announced an investment in Stockheim Media GmbH, the German business communications consultancy. Stockheim Media operates from offices in Frankfurt and Cologne, and is highly regarded in Germany for its work in strategic communications consulting. It has a particular strength in the financial services sector. Including the existing Life Sciences team, College Hill now employs over 30 people in Germany, operating from offices in Frankfurt, Cologne and Munich. College Hill and Stockheim Media will together expand coverage of German capital markets, combining Stockheim Media's strong local reputation with College Hill's growing international capital markets practice. Ulrich Stockheim, founder and Managing Partner of Stockheim Media, says 'We like College Hill's ambition and culture. We are remarkably similar. Combining our strong local relationships with their capital markets expertise creates a powerful offering in Germany'.
Read this press release...
|
|
 |
College Hill - Life Sciences
London Tel: +44 (0)20 7457 2020
Manchester Tel: +44 (0)1260 296 500
Munich Tel: +49 (0)89 5700 1806
www.collegehill-lifesciences.com |
|
|
|
| |
